EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Cell‐free epigenomes enhanced fragmentomics‐based model for early detection of lung cancer

Yadong Wang, Qiang Guo, Zhicheng Huang, Liyang Song, Fei Zhao, Tiantian Gu, Zhe Feng, Haibo Wang, Bowen Li, Daoyun Wang, Bin Zhou, Chao Guo und 21 weitere

Clinical and Translational Medicine · 2025

DOI: 10.1002/ctm2.70225 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical and Translational Medicine, 2025. Verfasst von Yadong Wang und 32 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing,…. Hauptthemen laut MEDLINE: Lung Neoplasms, Early Detection of Cancer, Cell-Free Nucleic Acids, Epigenome. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National High Level Hospital Clinical Research Funding, Chinese Society of Clinical Oncology fund, Shanghai Weihe Medical Laboratory Co., Ltd.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lung cancer is a leading cause of cancer mortality, highlighting the need for innovative non‐invasive early detection methods. Although cell‐free DNA (cfDNA) analysis shows promise, its sensitivity in early‐stage lung cancer patients remains a challenge. This study aimed to integrate insights from epigenetic modifications and fragmentomic features of cfDNA using machine learning to develop a more accurate lung cancer detection model.

Methods

To address this issue, a multi‐centre prospective cohort study was conducted, with participants harbouring suspicious malignant lung nodules and healthy volunteers recruited from two clinical centres. Plasma cfDNA was analysed for its epigenetic and fragmentomic profiles using chromatin immunoprecipitation sequencing, reduced representation bisulphite sequencing and low‐pass whole‐genome sequencing. Machine learning algorithms were then employed to integrate the multi‐omics data, aiding in the development of a precise lung cancer detection model.

Results

Cancer‐related changes in cfDNA fragmentomics were significantly enriched in specific genes marked by cell‐free epigenomes. A total of 609 genes were identified, and the corresponding cfDNA fragmentomic features were utilised to construct the ensemble model. This model achieved a sensitivity of 90.4% and a specificity of 83.1%, with an AUC of 0.94 in the independent validation set. Notably, the model demonstrated exceptional sensitivity for stage I lung cancer cases, achieving 95.1%. It also showed remarkable performance in detecting minimally invasive adenocarcinoma, with a sensitivity of 96.2%, highlighting its potential for early detection in clinical settings.

Conclusions

With feature selection guided by multiple epigenetic sequencing approaches, the cfDNA fragmentomics‐based machine learning model demonstrated outstanding performance in the independent validation cohort. These findings highlight its potential as an effective non‐invasive strategy for the early detection of lung cancer. Keypoints Our study elucidated the regulatory relationships between epigenetic modifications and their effects on fragmentomic features. Identifying epigenetically regulated genes provided a critical foundation for developing the cfDNA fragmentomics‐based machine learning model. The model demonstrated exceptional clinical performance, highlighting its substantial potential for translational application in clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsEarly Detection of CancerCell-Free Nucleic AcidsEpigenomeEpigenomicsHumansProspective StudiesMaleFemaleMiddle AgedAgedMachine LearningBiomarkers, TumorEpigenesis, Genetic

Stichwörter der Autor:innen

cell‐free DNAearly cancer screeningepigenomicsliquid biopsylung cancer

Substanzen

Cell-Free Nucleic AcidsBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Department of Thoracic Surgery, Affiliated Hospital of Hebei University, Baoding, China.
  • Shanghai Weihe Medical Laboratory Co., Ltd, Shanghai, China.
  • Department of Cardiothoracic Surgery, the Sixth Hospital of Beijing, Beijing, China.
  • Department of Scientific Research, Affiliated Hospital of Hebei University, Baoding, China.

ORCID-Profile: Haochen Li, Jianhong Shi, Naixin Liang

Förderung

  • National High Level Hospital Clinical Research Funding
  • Chinese Society of Clinical Oncology fund
  • Shanghai Weihe Medical Laboratory Co., Ltd

Zitieren

APA

Wang, Y., Guo, Q., Huang, Z., Song, L., Zhao, F., Gu, T., Feng, Z., Wang, H., Li, B., Wang, D., Zhou, B., Guo, C., Xu, Y., Song, Y., Zheng, Z., Bing, Z., Li, H., Yu, X., Fung, K. L., …, & Liang, N. (2025). Cell‐free epigenomes enhanced fragmentomics‐based model for early detection of lung cancer. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.70225

Vancouver

Wang Y, Guo Q, Huang Z, Song L, Zhao F, Gu T, et al. Cell‐free epigenomes enhanced fragmentomics‐based model for early detection of lung cancer. Clinical and Translational Medicine. 2025. doi:10.1002/ctm2.70225

BibTeX
@article{Wang2025,
  author = {Wang, Yadong and Guo, Qiang and Huang, Zhicheng and Song, Liyang and Zhao, Fei and Gu, Tiantian and Feng, Zhe and Wang, Haibo and Li, Bowen and Wang, Daoyun and Zhou, Bin and Guo, Chao and Xu, Yuan and Song, Yang and Zheng, Zhibo and Bing, Zhongxing and Li, Haochen and Yu, Xiaoqing and Fung, Ka Luk and Xu, Heqing and Shi, Jianhong and Chen, Meng and Hong, Shuai and Jin, Haoxuan and Tong, Shiyuan and Zhu, Sibo and Zhu, Chen and Song, Jinlei and Liu, Jing and Li, Shanqing and Li, Hefei and Sun, Xueguang and Liang, Naixin},
  title = {Cell‐free epigenomes enhanced fragmentomics‐based model for early detection of lung cancer},
  journal = {Clinical and Translational Medicine},
  year = {2025},
  doi = {10.1002/ctm2.70225}
}
Kostenlos starten →